IDiyas

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

James A Aikins

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1989 - 2002)
  • Pendleton, IN (US) (2002 - 2004)

Company Filing History:

goldMedal14 out of 4,442 
 
Eli Lilly and Company
 patents

Years Active: 1989-2004

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6803484 - Sulfonamide derivatives (2004-10-12),
2. 6639107 - Cyclopentyl sulfonamide derivatives (2003-10-28),
3. 6376230 - Stereoselective process for producing intermediates of cryptophycins (2002-04-23),
4. 6372945 - Process for the synthesis of vinyl sulfoxides (2002-04-16),
5. 6372936 - Optical resolution of aminoisobobutyric acid (2002-04-16),
6. 5659087 - Diarylvinyl sulfoxides (1997-08-19),
7. 5637692 - Azetidinone intermediates to carbacephalosporins and process (1997-06-10),
8. 5606076 - Process for the synthesis of benzo[b]thiophenes (1997-02-25),
9. 5594028 - Anti-tumor method and compounds (1997-01-14),
10. 5453503 - Azetidinone intermediates to carbacephalosporins and process (1995-09-26),
11. 5453502 - 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and (1995-09-26),
12. 5225553 - Intermediates to 1-carbacephalosporins and process for preparation (1993-07-06),
13. 5159073 - Intermediates to 1-carbacephalosporins and process for preparation (1992-10-27),
14. 4820845 - Alkylation of 3(5)-cyano-1H-pyrazole-4-carboxylic acid esters (1989-04-11),

Title: The Innovative Contributions of James A Aikins

Introduction

James A Aikins is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address psychiatric and neurological disorders. With a total of 14 patents to his name, Aikins continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents, Aikins has developed sulfonamide derivatives that are useful for treating conditions associated with glutamate hypofunction. This includes psychiatric and neurological disorders, showcasing his commitment to addressing critical health issues. Another notable patent involves cyclopentyl sulfonamide derivatives, which are designed to potentiate glutamate receptor function in mammals. This invention not only includes novel derivatives but also outlines processes for their preparation and pharmaceutical compositions containing them.

Career Highlights

Aikins is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to pharmaceutical science.

Collaborations

Some of his notable coworkers include Eddie V Tao and Tony Yantao Zhang. Their collaborative efforts have undoubtedly enriched the research environment and fostered innovation within their projects.

Conclusion

James A Aikins exemplifies the spirit of innovation in the pharmaceutical industry. His work continues to have a profound impact on the treatment of complex health conditions, making him a valuable asset to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…